# Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis

> **NCT01356004** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 35 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** live attenuated chicken pox vaccine
- **DRUG:** saline, efficacy

## Key facts

- **NCT ID:** NCT01356004
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-05
- **Final completion:** 2010-11
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356004, "Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01356004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*